How many insider trades does FilingIQ track for ABCL?

FilingIQ tracks 105 Form 4 insider transactions for ABCL (AbCellera Biologics Inc.), covering filings from Nov 6, 2020 onwards. 3 of those were filed in the last 90 days.

Are ABCL insiders net buyers or net sellers?

Across the full Form 4 history for ABCL, 40 transactions (38%) were open-market purchases and 10 (10%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ABCL insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ABCL in?

AbCellera Biologics Inc. (ABCL) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.04B.

ABCL insider trading

NasdaqGS Healthcare

AbCellera Biologics Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

105

Last 90 days

Buys / sells

38% / 10%

Market cap

$1.04B

About AbCellera Biologics Inc.

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Company website: www.abcellera.com

ABCL insider activity at a glance

FilingIQ has scored 105 insider transactions for ABCL since Nov 6, 2020. The most recent filing in our index is dated Feb 27, 2026.

Across the full history, 40 open-market purchases and 10 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ABCL insider trades is 54.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ABCL trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for ABCL?: FilingIQ tracks 105 Form 4 insider transactions for ABCL (AbCellera Biologics Inc.), covering filings from Nov 6, 2020 onwards. 3 of those were filed in the last 90 days.
Are ABCL insiders net buyers or net sellers?: Across the full Form 4 history for ABCL, 40 transactions (38%) were open-market purchases and 10 (10%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ABCL insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ABCL in?: AbCellera Biologics Inc. (ABCL) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.04B.

Methodology & sources

Every ABCL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.